Results from a new study of Japanese patients with type 2 diabetes showed once-weekly Trulicity ™ 0.75 mg provided greater hemoglobin A1c (A1C) reduction compared to once-daily Victoza ® 0.9 mg after ...
Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise The single-dose pen does not require mixing nor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results